Literature DB >> 3962185

Anti-idiotypic antibodies to monoclonal antibodies that neutralize coxsackievirus B4 do not recognize viral receptors.

P R McClintock, B S Prabhakar, A L Notkins.   

Abstract

We have made anti-idiotypic antibodies in rabbits against three mouse monoclonal neutralizing antibodies with specificities for independent epitopes on Coxsackievirus B4. Each of these anti-idiotypic antibodies was found to react specifically with the immunizing monoclonal antibody in radioimmunoassays and did not react with the other monoclonal antibodies. In addition, the anti-idiotypic antibodies specifically inhibited the function (i.e., virus neutralization) of the immunizing antibody. These anti-idiotypic antibodies were tested for their ability to recognize receptors for Coxsackievirus B4 as measured by their ability to inhibit the attachment of radiolabeled virus to cellular receptors. The anti-idiotypic antibodies did not block the binding of Coxsackievirus B4 to monkey kidney cells. Moreover, when tested for their ability to bind to other receptor positive cells, none of the anti-idiotypic antibodies bound above control levels. Anti-idiotypic antibodies did induce a small anti-anti-idiotypic antibody response in mice when tested by radioimmunoassay; however, little if any virus neutralizing activity was found in the sera of these mice. Our results contrast to those reported for anti-idiotypic antibodies in several other virus systems and suggest that not all anti-idiotypic antibodies made against neutralizing antibodies are capable of eliciting an antiviral immune response or binding to viral viral receptors on cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3962185     DOI: 10.1016/0042-6822(86)90300-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  5 in total

1.  Identification of a putative shared epitope between Coxsackie virus B4 and alpha cardiac myosin heavy chain.

Authors:  K W Beisel; J Srinivasappa; B S Prabhakar
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  Anti-idiotypic antibodies to rubella virus.

Authors:  A Nath; B Slagle; J S Wolinsky
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Monoclonal anti-idiotypes induce neutralizing antibodies to enterovirus 70 conformational epitopes.

Authors:  J A Wiley; J Hamel; B R Brodeur
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 4.  Moloney leukemia virus-induced cell surface antigen mimicry by monoclonal antibodies.

Authors:  J G Baskin; T J Powell; R V Srinivas; M Elliott; E W Lamon
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 5.  Genetic variability: the key problem in the prevention and therapy of RNA-based virus infections.

Authors:  Magdalena Figlerowicz; Magdalena Alejska; Anna Kurzyńska-Kokorniak; Marek Figlerowicz
Journal:  Med Res Rev       Date:  2003-07       Impact factor: 12.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.